Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhythm Biosciences.
RELATED STOCKHEAD STORIES
Director Trades
Directors’ Trades: Otto Buttula buys another $580k of Rhythm Biosciences shares
Health & Biotech
ASX Health Stocks: NeuroScientific soars 10pc on COVID-19 drug, Telix advances prostate cancer studies
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
IPO Watch
IPO Watch: There’s another company seeking to detect cancer using blood tests listing on the ASX next week
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
News
Last Orders: ASX teeters on the edge of 7,400
News
Market highlights and 5 ASX small caps to watch on Wednesday
Experts
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market
News
Last Orders: Resources and energy keep ASX in green territory
Health & Biotech
Imugene led a biotech buying frenzy on the ASX today
News
Last Orders: Tech leads the ASX into negative territory
News
Here are the 10 best ASX stocks since COVID-19 began; they’re up over 2000pc
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
Health & Biotech
Cancer diagnostics stock Bard1 gains another 40pc with more positive data
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
Health & Biotech
